HMLEE personal page - To The Moon

HMLEE

No personal profile

3Follow

2Followers

0Topic

0Badge

2021-06-29

Good one

Sorry, the original content has been removed

2021-06-30

.

China Cancer Drugmaker Surges 28% in Hong Kong Trading Debut

2021-06-29

$ISDN HOLDINGS LIMITED(I07.SI)$ Huat ar

2021-06-29

Wow

China stocks end lower as virus cases threaten global recovery

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3583141439554126","uuid":"3583141439554126","gmtCreate":1620048603309,"gmtModify":1620048603309,"name":"HMLEE","pinyin":"hmlee","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":3,"tweetSize":4,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.02.06","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":153847416,"gmtCreate":1625019220735,"gmtModify":1703850246815,"author":{"id":"3583141439554126","authorId":"3583141439554126","name":"HMLEE","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583141439554126","authorIdStr":"3583141439554126"},"themes":[],"htmlText":".","listText":".","text":".","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/153847416","repostId":"1124855646","repostType":4,"repost":{"id":"1124855646","pubTimestamp":1625018860,"share":"https://ttm.financial/m/news/1124855646?lang=&edition=fundamental","pubTime":"2021-06-30 10:07","market":"hk","language":"en","title":"China Cancer Drugmaker Surges 28% in Hong Kong Trading Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1124855646","media":"Bloomberg","summary":"Hutchmed (China) Ltd., a cancer drug developer backed by billionaire Li Ka-shing, jumped in its firs","content":"<p>Hutchmed (China) Ltd., a cancer drug developer backed by billionaire Li Ka-shing, jumped in its first day of trade in Hong Kong about two years after it delayed a previous attempt to list in the city.</p>\n<p>Shares of the biopharmaceutical company that already trades in the U.S. and the U.K. opened at HK$51.40 on Wednesday, up 28% from their offer price of HK$40.10. Hutchmedraised$537 million in the offering. It had initially planned a listing in Hong Kong in 2019, but the plan wasshelvedamid market uncertainties at the time.</p>\n<p>Hutchmed’s debut comes after a stellar first half of the year for first-time share sales in the Asian financial hub, with a record $28 billion raised, data compiled by Bloomberg show.</p>\n<p>Prior to Wednesday, almost 59% of the 44 companies that started trading in Hong Kong this year ended their first session higher than the listing price, with eight of them popping more than 50% on their debuts, data compiled by Bloomberg show.</p>\n<p>Shares of property management firmYuexiu Services Group Ltd. ended their first day of trading on Monday flat from their IPO price of HK$4.88. That contrasts with a 259% jump forMorimatsu International Holdings, a Chinese pressure equipment manufacturer which debuted the same day. Earlier this month, China Youran Dairy Group slumped 12% after its $643 millionIPO.</p>\n<p>Chinese bubble tea chain Nayuki Holdings Ltd. fell 5% on its Hong Kong debut on Wednesday.</p>\n<p>Hutchmed’s stock inNew Yorkis up 3.8% this year, while the London-listed shareshave risen 3.3%.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China Cancer Drugmaker Surges 28% in Hong Kong Trading Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina Cancer Drugmaker Surges 28% in Hong Kong Trading Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-30 10:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-30/china-cancer-drugmaker-surges-28-in-hong-kong-trading-debut><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Hutchmed (China) Ltd., a cancer drug developer backed by billionaire Li Ka-shing, jumped in its first day of trade in Hong Kong about two years after it delayed a previous attempt to list in the city....</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-30/china-cancer-drugmaker-surges-28-in-hong-kong-trading-debut\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"00013":"和黄医药","HCM":"和黄医药"},"source_url":"https://www.bloomberg.com/news/articles/2021-06-30/china-cancer-drugmaker-surges-28-in-hong-kong-trading-debut","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1124855646","content_text":"Hutchmed (China) Ltd., a cancer drug developer backed by billionaire Li Ka-shing, jumped in its first day of trade in Hong Kong about two years after it delayed a previous attempt to list in the city.\nShares of the biopharmaceutical company that already trades in the U.S. and the U.K. opened at HK$51.40 on Wednesday, up 28% from their offer price of HK$40.10. Hutchmedraised$537 million in the offering. It had initially planned a listing in Hong Kong in 2019, but the plan wasshelvedamid market uncertainties at the time.\nHutchmed’s debut comes after a stellar first half of the year for first-time share sales in the Asian financial hub, with a record $28 billion raised, data compiled by Bloomberg show.\nPrior to Wednesday, almost 59% of the 44 companies that started trading in Hong Kong this year ended their first session higher than the listing price, with eight of them popping more than 50% on their debuts, data compiled by Bloomberg show.\nShares of property management firmYuexiu Services Group Ltd. ended their first day of trading on Monday flat from their IPO price of HK$4.88. That contrasts with a 259% jump forMorimatsu International Holdings, a Chinese pressure equipment manufacturer which debuted the same day. Earlier this month, China Youran Dairy Group slumped 12% after its $643 millionIPO.\nChinese bubble tea chain Nayuki Holdings Ltd. fell 5% on its Hong Kong debut on Wednesday.\nHutchmed’s stock inNew Yorkis up 3.8% this year, while the London-listed shareshave risen 3.3%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":146,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":159846478,"gmtCreate":1624958215794,"gmtModify":1703848825754,"author":{"id":"3583141439554126","authorId":"3583141439554126","name":"HMLEE","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583141439554126","authorIdStr":"3583141439554126"},"themes":[],"htmlText":"Good one","listText":"Good one","text":"Good one","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/159846478","repostId":"2147832042","repostType":4,"isVote":1,"tweetType":1,"viewCount":330,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":159848418,"gmtCreate":1624958173034,"gmtModify":1703848824132,"author":{"id":"3583141439554126","authorId":"3583141439554126","name":"HMLEE","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583141439554126","authorIdStr":"3583141439554126"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/I07.SI\">$ISDN HOLDINGS LIMITED(I07.SI)$</a> Huat ar","listText":"<a href=\"https://laohu8.com/S/I07.SI\">$ISDN HOLDINGS LIMITED(I07.SI)$</a> Huat ar","text":"$ISDN HOLDINGS LIMITED(I07.SI)$ Huat ar","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/159848418","isVote":1,"tweetType":1,"viewCount":293,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":159849879,"gmtCreate":1624957978891,"gmtModify":1703848822518,"author":{"id":"3583141439554126","authorId":"3583141439554126","name":"HMLEE","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583141439554126","authorIdStr":"3583141439554126"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/159849879","repostId":"2147854949","repostType":4,"repost":{"id":"2147854949","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1624953169,"share":"https://ttm.financial/m/news/2147854949?lang=&edition=fundamental","pubTime":"2021-06-29 15:52","market":"sh","language":"en","title":"China stocks end lower as virus cases threaten global recovery","url":"https://stock-news.laohu8.com/highlight/detail?id=2147854949","media":"Reuters","summary":"SHANGHAI, June 29 (Reuters) - China stocks fell on Tuesday on concerns the infectious Delta virus va","content":"<p>SHANGHAI, June 29 (Reuters) - China stocks fell on Tuesday on concerns the infectious Delta virus variant could assuage global economic recovery, while investors refrained from placing big bets ahead of U.S. jobs data, which could sway the Federal Reserve's policy outlook.</p>\n<p>The blue-chip CSI300 index closed 1.2% lower at 5,190.54, snapping a five-day winning streak, while the Shanghai Composite Index shed 0.9% to 3,573.18.</p>\n<p>Markets are on edge after the Fed shocked traders with a hawkish tilt earlier this month, while investors adopted a wait-and-watch mode ahead of the U.S. June employment report.</p>\n<p>The retreat from riskier assets followed reports of more contagious Delta COVID-19 strain spread in Asia and elsewhere, stoking fears of further lockdowns.</p>\n<p>The CSI300 financials index declined 1.3%, while the CSI300 consumer staples index dropped 1.8%.</p>\n<p>China will make its monetary policy flexible, targeted and appropriate, while keeping interbank liquidity reasonable, the central bank said on Monday, as authorities seek to consolidate a post-COVID-19 economic recovery.</p>\n<p>The country's economy has seen a rebound from the impact of the COVID-19 pandemic, with Chinese exporters racing ahead to fill global demand bolstering the vast industry sector, but the recovery in the consumer end has been weak.</p>\n<p>\"The net injection by the PBOC was to smoothen liquidity across quarters and the PBOC would probably go back to drain short-term liquidity, while large inflows via the Stock Connect are unsustainable against a backdrop of a stronger dollar,\" Yan Kaiwen, an analyst with China Fortune Securities said.</p>\n<p>Shares in China's leading battery maker CATL hit an all-time high before closing 3% higher after the company extended a battery supply deal with Tesla Inc to 2025.</p>\n<p>According to Refinitiv data, investors via the Stock Connect linking mainland and Hong Kong sold net 1.3 billion yuan&nbsp;($201.31 million) worth of A-shares on Tuesday.</p>\n<p>($1 = 6.4578 Chinese yuan)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China stocks end lower as virus cases threaten global recovery</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina stocks end lower as virus cases threaten global recovery\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-29 15:52</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>SHANGHAI, June 29 (Reuters) - China stocks fell on Tuesday on concerns the infectious Delta virus variant could assuage global economic recovery, while investors refrained from placing big bets ahead of U.S. jobs data, which could sway the Federal Reserve's policy outlook.</p>\n<p>The blue-chip CSI300 index closed 1.2% lower at 5,190.54, snapping a five-day winning streak, while the Shanghai Composite Index shed 0.9% to 3,573.18.</p>\n<p>Markets are on edge after the Fed shocked traders with a hawkish tilt earlier this month, while investors adopted a wait-and-watch mode ahead of the U.S. June employment report.</p>\n<p>The retreat from riskier assets followed reports of more contagious Delta COVID-19 strain spread in Asia and elsewhere, stoking fears of further lockdowns.</p>\n<p>The CSI300 financials index declined 1.3%, while the CSI300 consumer staples index dropped 1.8%.</p>\n<p>China will make its monetary policy flexible, targeted and appropriate, while keeping interbank liquidity reasonable, the central bank said on Monday, as authorities seek to consolidate a post-COVID-19 economic recovery.</p>\n<p>The country's economy has seen a rebound from the impact of the COVID-19 pandemic, with Chinese exporters racing ahead to fill global demand bolstering the vast industry sector, but the recovery in the consumer end has been weak.</p>\n<p>\"The net injection by the PBOC was to smoothen liquidity across quarters and the PBOC would probably go back to drain short-term liquidity, while large inflows via the Stock Connect are unsustainable against a backdrop of a stronger dollar,\" Yan Kaiwen, an analyst with China Fortune Securities said.</p>\n<p>Shares in China's leading battery maker CATL hit an all-time high before closing 3% higher after the company extended a battery supply deal with Tesla Inc to 2025.</p>\n<p>According to Refinitiv data, investors via the Stock Connect linking mainland and Hong Kong sold net 1.3 billion yuan&nbsp;($201.31 million) worth of A-shares on Tuesday.</p>\n<p>($1 = 6.4578 Chinese yuan)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"399001":"深证成指","399006":"创业板指","000001.SH":"上证指数"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2147854949","content_text":"SHANGHAI, June 29 (Reuters) - China stocks fell on Tuesday on concerns the infectious Delta virus variant could assuage global economic recovery, while investors refrained from placing big bets ahead of U.S. jobs data, which could sway the Federal Reserve's policy outlook.\nThe blue-chip CSI300 index closed 1.2% lower at 5,190.54, snapping a five-day winning streak, while the Shanghai Composite Index shed 0.9% to 3,573.18.\nMarkets are on edge after the Fed shocked traders with a hawkish tilt earlier this month, while investors adopted a wait-and-watch mode ahead of the U.S. June employment report.\nThe retreat from riskier assets followed reports of more contagious Delta COVID-19 strain spread in Asia and elsewhere, stoking fears of further lockdowns.\nThe CSI300 financials index declined 1.3%, while the CSI300 consumer staples index dropped 1.8%.\nChina will make its monetary policy flexible, targeted and appropriate, while keeping interbank liquidity reasonable, the central bank said on Monday, as authorities seek to consolidate a post-COVID-19 economic recovery.\nThe country's economy has seen a rebound from the impact of the COVID-19 pandemic, with Chinese exporters racing ahead to fill global demand bolstering the vast industry sector, but the recovery in the consumer end has been weak.\n\"The net injection by the PBOC was to smoothen liquidity across quarters and the PBOC would probably go back to drain short-term liquidity, while large inflows via the Stock Connect are unsustainable against a backdrop of a stronger dollar,\" Yan Kaiwen, an analyst with China Fortune Securities said.\nShares in China's leading battery maker CATL hit an all-time high before closing 3% higher after the company extended a battery supply deal with Tesla Inc to 2025.\nAccording to Refinitiv data, investors via the Stock Connect linking mainland and Hong Kong sold net 1.3 billion yuan ($201.31 million) worth of A-shares on Tuesday.\n($1 = 6.4578 Chinese yuan)","news_type":1},"isVote":1,"tweetType":1,"viewCount":167,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":159846478,"gmtCreate":1624958215794,"gmtModify":1703848825754,"author":{"id":"3583141439554126","authorId":"3583141439554126","name":"HMLEE","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583141439554126","authorIdStr":"3583141439554126"},"themes":[],"htmlText":"Good one","listText":"Good one","text":"Good one","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/159846478","repostId":"2147832042","repostType":4,"isVote":1,"tweetType":1,"viewCount":330,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":153847416,"gmtCreate":1625019220735,"gmtModify":1703850246815,"author":{"id":"3583141439554126","authorId":"3583141439554126","name":"HMLEE","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583141439554126","authorIdStr":"3583141439554126"},"themes":[],"htmlText":".","listText":".","text":".","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/153847416","repostId":"1124855646","repostType":4,"repost":{"id":"1124855646","pubTimestamp":1625018860,"share":"https://ttm.financial/m/news/1124855646?lang=&edition=fundamental","pubTime":"2021-06-30 10:07","market":"hk","language":"en","title":"China Cancer Drugmaker Surges 28% in Hong Kong Trading Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1124855646","media":"Bloomberg","summary":"Hutchmed (China) Ltd., a cancer drug developer backed by billionaire Li Ka-shing, jumped in its firs","content":"<p>Hutchmed (China) Ltd., a cancer drug developer backed by billionaire Li Ka-shing, jumped in its first day of trade in Hong Kong about two years after it delayed a previous attempt to list in the city.</p>\n<p>Shares of the biopharmaceutical company that already trades in the U.S. and the U.K. opened at HK$51.40 on Wednesday, up 28% from their offer price of HK$40.10. Hutchmedraised$537 million in the offering. It had initially planned a listing in Hong Kong in 2019, but the plan wasshelvedamid market uncertainties at the time.</p>\n<p>Hutchmed’s debut comes after a stellar first half of the year for first-time share sales in the Asian financial hub, with a record $28 billion raised, data compiled by Bloomberg show.</p>\n<p>Prior to Wednesday, almost 59% of the 44 companies that started trading in Hong Kong this year ended their first session higher than the listing price, with eight of them popping more than 50% on their debuts, data compiled by Bloomberg show.</p>\n<p>Shares of property management firmYuexiu Services Group Ltd. ended their first day of trading on Monday flat from their IPO price of HK$4.88. That contrasts with a 259% jump forMorimatsu International Holdings, a Chinese pressure equipment manufacturer which debuted the same day. Earlier this month, China Youran Dairy Group slumped 12% after its $643 millionIPO.</p>\n<p>Chinese bubble tea chain Nayuki Holdings Ltd. fell 5% on its Hong Kong debut on Wednesday.</p>\n<p>Hutchmed’s stock inNew Yorkis up 3.8% this year, while the London-listed shareshave risen 3.3%.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China Cancer Drugmaker Surges 28% in Hong Kong Trading Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina Cancer Drugmaker Surges 28% in Hong Kong Trading Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-30 10:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-30/china-cancer-drugmaker-surges-28-in-hong-kong-trading-debut><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Hutchmed (China) Ltd., a cancer drug developer backed by billionaire Li Ka-shing, jumped in its first day of trade in Hong Kong about two years after it delayed a previous attempt to list in the city....</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-30/china-cancer-drugmaker-surges-28-in-hong-kong-trading-debut\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"00013":"和黄医药","HCM":"和黄医药"},"source_url":"https://www.bloomberg.com/news/articles/2021-06-30/china-cancer-drugmaker-surges-28-in-hong-kong-trading-debut","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1124855646","content_text":"Hutchmed (China) Ltd., a cancer drug developer backed by billionaire Li Ka-shing, jumped in its first day of trade in Hong Kong about two years after it delayed a previous attempt to list in the city.\nShares of the biopharmaceutical company that already trades in the U.S. and the U.K. opened at HK$51.40 on Wednesday, up 28% from their offer price of HK$40.10. Hutchmedraised$537 million in the offering. It had initially planned a listing in Hong Kong in 2019, but the plan wasshelvedamid market uncertainties at the time.\nHutchmed’s debut comes after a stellar first half of the year for first-time share sales in the Asian financial hub, with a record $28 billion raised, data compiled by Bloomberg show.\nPrior to Wednesday, almost 59% of the 44 companies that started trading in Hong Kong this year ended their first session higher than the listing price, with eight of them popping more than 50% on their debuts, data compiled by Bloomberg show.\nShares of property management firmYuexiu Services Group Ltd. ended their first day of trading on Monday flat from their IPO price of HK$4.88. That contrasts with a 259% jump forMorimatsu International Holdings, a Chinese pressure equipment manufacturer which debuted the same day. Earlier this month, China Youran Dairy Group slumped 12% after its $643 millionIPO.\nChinese bubble tea chain Nayuki Holdings Ltd. fell 5% on its Hong Kong debut on Wednesday.\nHutchmed’s stock inNew Yorkis up 3.8% this year, while the London-listed shareshave risen 3.3%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":146,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":159848418,"gmtCreate":1624958173034,"gmtModify":1703848824132,"author":{"id":"3583141439554126","authorId":"3583141439554126","name":"HMLEE","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583141439554126","authorIdStr":"3583141439554126"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/I07.SI\">$ISDN HOLDINGS LIMITED(I07.SI)$</a> Huat ar","listText":"<a href=\"https://laohu8.com/S/I07.SI\">$ISDN HOLDINGS LIMITED(I07.SI)$</a> Huat ar","text":"$ISDN HOLDINGS LIMITED(I07.SI)$ Huat ar","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/159848418","isVote":1,"tweetType":1,"viewCount":293,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":159849879,"gmtCreate":1624957978891,"gmtModify":1703848822518,"author":{"id":"3583141439554126","authorId":"3583141439554126","name":"HMLEE","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583141439554126","authorIdStr":"3583141439554126"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/159849879","repostId":"2147854949","repostType":4,"repost":{"id":"2147854949","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1624953169,"share":"https://ttm.financial/m/news/2147854949?lang=&edition=fundamental","pubTime":"2021-06-29 15:52","market":"sh","language":"en","title":"China stocks end lower as virus cases threaten global recovery","url":"https://stock-news.laohu8.com/highlight/detail?id=2147854949","media":"Reuters","summary":"SHANGHAI, June 29 (Reuters) - China stocks fell on Tuesday on concerns the infectious Delta virus va","content":"<p>SHANGHAI, June 29 (Reuters) - China stocks fell on Tuesday on concerns the infectious Delta virus variant could assuage global economic recovery, while investors refrained from placing big bets ahead of U.S. jobs data, which could sway the Federal Reserve's policy outlook.</p>\n<p>The blue-chip CSI300 index closed 1.2% lower at 5,190.54, snapping a five-day winning streak, while the Shanghai Composite Index shed 0.9% to 3,573.18.</p>\n<p>Markets are on edge after the Fed shocked traders with a hawkish tilt earlier this month, while investors adopted a wait-and-watch mode ahead of the U.S. June employment report.</p>\n<p>The retreat from riskier assets followed reports of more contagious Delta COVID-19 strain spread in Asia and elsewhere, stoking fears of further lockdowns.</p>\n<p>The CSI300 financials index declined 1.3%, while the CSI300 consumer staples index dropped 1.8%.</p>\n<p>China will make its monetary policy flexible, targeted and appropriate, while keeping interbank liquidity reasonable, the central bank said on Monday, as authorities seek to consolidate a post-COVID-19 economic recovery.</p>\n<p>The country's economy has seen a rebound from the impact of the COVID-19 pandemic, with Chinese exporters racing ahead to fill global demand bolstering the vast industry sector, but the recovery in the consumer end has been weak.</p>\n<p>\"The net injection by the PBOC was to smoothen liquidity across quarters and the PBOC would probably go back to drain short-term liquidity, while large inflows via the Stock Connect are unsustainable against a backdrop of a stronger dollar,\" Yan Kaiwen, an analyst with China Fortune Securities said.</p>\n<p>Shares in China's leading battery maker CATL hit an all-time high before closing 3% higher after the company extended a battery supply deal with Tesla Inc to 2025.</p>\n<p>According to Refinitiv data, investors via the Stock Connect linking mainland and Hong Kong sold net 1.3 billion yuan&nbsp;($201.31 million) worth of A-shares on Tuesday.</p>\n<p>($1 = 6.4578 Chinese yuan)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China stocks end lower as virus cases threaten global recovery</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina stocks end lower as virus cases threaten global recovery\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-29 15:52</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>SHANGHAI, June 29 (Reuters) - China stocks fell on Tuesday on concerns the infectious Delta virus variant could assuage global economic recovery, while investors refrained from placing big bets ahead of U.S. jobs data, which could sway the Federal Reserve's policy outlook.</p>\n<p>The blue-chip CSI300 index closed 1.2% lower at 5,190.54, snapping a five-day winning streak, while the Shanghai Composite Index shed 0.9% to 3,573.18.</p>\n<p>Markets are on edge after the Fed shocked traders with a hawkish tilt earlier this month, while investors adopted a wait-and-watch mode ahead of the U.S. June employment report.</p>\n<p>The retreat from riskier assets followed reports of more contagious Delta COVID-19 strain spread in Asia and elsewhere, stoking fears of further lockdowns.</p>\n<p>The CSI300 financials index declined 1.3%, while the CSI300 consumer staples index dropped 1.8%.</p>\n<p>China will make its monetary policy flexible, targeted and appropriate, while keeping interbank liquidity reasonable, the central bank said on Monday, as authorities seek to consolidate a post-COVID-19 economic recovery.</p>\n<p>The country's economy has seen a rebound from the impact of the COVID-19 pandemic, with Chinese exporters racing ahead to fill global demand bolstering the vast industry sector, but the recovery in the consumer end has been weak.</p>\n<p>\"The net injection by the PBOC was to smoothen liquidity across quarters and the PBOC would probably go back to drain short-term liquidity, while large inflows via the Stock Connect are unsustainable against a backdrop of a stronger dollar,\" Yan Kaiwen, an analyst with China Fortune Securities said.</p>\n<p>Shares in China's leading battery maker CATL hit an all-time high before closing 3% higher after the company extended a battery supply deal with Tesla Inc to 2025.</p>\n<p>According to Refinitiv data, investors via the Stock Connect linking mainland and Hong Kong sold net 1.3 billion yuan&nbsp;($201.31 million) worth of A-shares on Tuesday.</p>\n<p>($1 = 6.4578 Chinese yuan)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"399001":"深证成指","399006":"创业板指","000001.SH":"上证指数"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2147854949","content_text":"SHANGHAI, June 29 (Reuters) - China stocks fell on Tuesday on concerns the infectious Delta virus variant could assuage global economic recovery, while investors refrained from placing big bets ahead of U.S. jobs data, which could sway the Federal Reserve's policy outlook.\nThe blue-chip CSI300 index closed 1.2% lower at 5,190.54, snapping a five-day winning streak, while the Shanghai Composite Index shed 0.9% to 3,573.18.\nMarkets are on edge after the Fed shocked traders with a hawkish tilt earlier this month, while investors adopted a wait-and-watch mode ahead of the U.S. June employment report.\nThe retreat from riskier assets followed reports of more contagious Delta COVID-19 strain spread in Asia and elsewhere, stoking fears of further lockdowns.\nThe CSI300 financials index declined 1.3%, while the CSI300 consumer staples index dropped 1.8%.\nChina will make its monetary policy flexible, targeted and appropriate, while keeping interbank liquidity reasonable, the central bank said on Monday, as authorities seek to consolidate a post-COVID-19 economic recovery.\nThe country's economy has seen a rebound from the impact of the COVID-19 pandemic, with Chinese exporters racing ahead to fill global demand bolstering the vast industry sector, but the recovery in the consumer end has been weak.\n\"The net injection by the PBOC was to smoothen liquidity across quarters and the PBOC would probably go back to drain short-term liquidity, while large inflows via the Stock Connect are unsustainable against a backdrop of a stronger dollar,\" Yan Kaiwen, an analyst with China Fortune Securities said.\nShares in China's leading battery maker CATL hit an all-time high before closing 3% higher after the company extended a battery supply deal with Tesla Inc to 2025.\nAccording to Refinitiv data, investors via the Stock Connect linking mainland and Hong Kong sold net 1.3 billion yuan ($201.31 million) worth of A-shares on Tuesday.\n($1 = 6.4578 Chinese yuan)","news_type":1},"isVote":1,"tweetType":1,"viewCount":167,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}